FDA Adverse Event Malfunction Summary report: N

INRATIO2 PT/INR TEST STRIPS

MDR report key: 5218021 · Received November 11, 2015

Report

Report Number
2027969-2015-00922
Event Type
Malfunction
Date Received
November 11, 2015
Date of Event
October 10, 2015
Report Date
October 16, 2015
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
K110212
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION PENDING.

Additional Manufacturer Narrative · 1

STRIP LOT K333796 EXPIRED IN OCTOBER 2014. NO OTHER COMPLAINTS WERE REPORTED FOR THIS STRIP LOT WHILE IT WAS WITHIN EXPIRATION. THEREFORE, NO INVESTIGATION WAS PERFORMED ON THIS LOT PRIOR TO ITS EXPIRATION. A REVIEW OF THE MANUFACTURING RECORDS FOR STRIP LOT K333796 DID NOT UNCOVER ANY RELEVANT NON-CONFORMANCES. THE LOT MEETS RELEASE SPECIFICATION. THE CUSTOMER WAS USING A PRODUCT WHICH HAD ALREADY BEEN EXPIRED FOR APPROXIMATELY A YEAR WHEN THEIR INRATIO TEST WAS PERFORMED. THIS CANNOT BE RULED OUT AS A CAUSE FOR THE UNEXPECTED RESULT. BASED ON THE INFORMATION AVAILABLE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. NO CORRECTIVE ACTION IS REQUIRED AT THIS TIME.

Description of Event or Problem · 1

THIS INCIDENT OCCURRED IN (B)(6). THE CALLER ALLEGED A VARIANCE BETWEEN INRATIO INR RESULTS AND THE LAB INR RESULTS. ON (B)(6) 2015, A PATIENT BROUGHT HIS INSTRUMENT BACK TO THE PHARMACY AND REQUESTED THAT THE VALUE RANGES BE CHECKED TO COMPARE WITH THE RESULTS OBSERVED WHEN HE TESTED HIMSELF ON (B)(6) 2015. THE RESULTS ON THAT DATE WERE AS FOLLOWS: INR RESULTS = 1.2 WHILE THE LAB INR = 2.4. THERAPEUTIC RANGE: NOT AVAILABLE. ALTHOUGH REQUESTED, NO FURTHER INFORMATION IS AVAILABLE. (NOTE: THIS MDR FILING IS DUE TO THE DEVICE BEING THE SAME OR SIMILAR AS A DEVICE AVAILABLE IN THE US).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
748820 INRATIO2 PT/INR TEST STRIPS PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. 99007EU K333796

Patients

Seq Age Sex Outcome Treatment
1